Comparing Treatment of Neovascular Age-related Macular Degeneration with Sequential Intravitreal Avastin and Macugen Versus Intravitreal Mono-therapy–A Pilot Study

Author： Schmid-Kubista Katharina E.   Krebs Ilse   Ansari-Shahrezaei Siamak   Haas Paulina   Hagen Stefan   Binder Susanne  

Publisher： Informa Healthcare

ISSN： 0271-3683

Source： Current Eye Research, Vol.36, Iss.10, 2011-10, pp. : 958-963

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Study of Intravitreal Bevacizumab (Avastin) versus Ranibizumab (Lucentis) in the Treatment of Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 223, Iss. 6, 2009-07 ,pp. : 370-375

Karger

Access to resources Recommend Favorite

A Pilot Study on the Combination Treatment of Reduced-Fluence Photodynamic Therapy, Intravitreal Ranibizumab, Intravitreal Dexamethasone and Oral Minocycline for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 225, Iss. 4, 2011-02 ,pp. : 200-206

Karger

Access to resources Recommend Favorite

Comparison of pro re nata versus Bimonthly Injection of Intravitreal Aflibercept for Typical Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 238, Iss. 1-2, 2017-04 ,pp. : 17-22

Karger

Access to resources Recommend Favorite

Photodynamic Therapy and Intravitreal Triamcinolone for Extrafoveal Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration

By  

Annals of Ophthalmology, Vol. 38, Iss. 3, 2006-09 ,pp. : 239-242

Humana Press, Inc

Access to resources Recommend Favorite

Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial

By  

Ophthalmologica, Vol. 234, Iss. 1, 2015-06 ,pp. : 40-54

Karger

Access to resources Recommend Favorite